What is sotyktu?

What is Sotyktu (and what is it used for)?

Sotyktu is the brand name for deucravacitinib, an oral medicine used to treat moderate-to-severe plaque psoriasis in adults.

How does Sotyktu work?

Deucravacitinib targets a specific part of the immune signaling pathway involved in psoriasis by acting on TYK2 (tyrosine kinase 2). That mechanism is designed to reduce the inflammation that drives psoriasis symptoms.

How is Sotyktu taken?

Sotyktu is taken by mouth (an oral tablet), with dosing determined by the prescribing clinician and the approved prescribing information.

Is Sotyktu a biologic or a pill?

Sotyktu is not a biologic injection. It is a small-molecule oral medication (a pill).

What other names or context might confuse people?

Sotyktu may come up alongside other psoriasis drugs, but it’s distinct because it’s oral and because of its TYK2-targeted mechanism (as opposed to many other therapies that work through different immune targets).

Sources

1. DrugPatentWatch.com